SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-121342
Filing Date
2017-04-12
Accepted
2017-04-12 16:00:57
Documents
2
Period of Report
2017-05-25
Effectiveness Date
2017-04-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A d354097ddef14a.htm DEF 14A 319905
2 GRAPHIC g354097g75x31.jpg GRAPHIC 2642
  Complete submission text file 0001193125-17-121342.txt   324829
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37519 | Film No.: 17758029
SIC: 2834 Pharmaceutical Preparations